Sunday, February 25, 2024
BestWooCommerceThemeBuilttoBoostSales-728x90

IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells – British Journal of Cancer


  • Han J, Won M, Kim JH, Jung E, Min K, Jangili P, et al. Cancer stem cell-targeted bio-imaging and chemotherapeutic perspective. Chem Soc Rev. 2020;49:7856–78.

    Article 
    PubMed 

    Google Scholar
     

  • Clarke MF. Clinical and therapeutic implications of cancer stem cells. N. Engl J Med. 2019;381:e19.

    Article 
    PubMed 

    Google Scholar
     

  • Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature. 2013;501:328–37.

    Article 
    ADS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Prager BC, Xie Q, Bao S, Rich JN. Cancer stem cells: the architects of the tumor ecosystem. Cell Stem Cell. 2019;24:41–53.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Yang Y, Li X, Wang T, Guo Q, Xi T, Zheng L. Emerging agents that target signaling pathways in cancer stem cells. J Hematol Oncol. 2020;13:60.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Song M, Ping Y, Zhang K, Yang L, Li F, Zhang C, et al. Low-Dose IFNgamma induces tumor cell stemness in tumor microenvironment of non-small cell lung cancer. Cancer Res. 2019;79:3737–48.

    Article 
    PubMed 

    Google Scholar
     

  • Dana H, Chalbatani GM, Jalali SA, Mirzaei HR, Grupp SA, Suarez ER, et al. CAR-T cells: early successes in blood cancer and challenges in solid tumors. Acta Pharm Sin B. 2021;11:1129–47.

    Article 
    PubMed 

    Google Scholar
     

  • Wei J, Guo Y, Wang Y, Wu Z, Bo J, Zhang B, et al. Clinical development of CAR T cell therapy in China: 2020 update. Cell Mol Immunol. 2021;18:792–804.

    Article 
    PubMed 

    Google Scholar
     

  • June CH, Sadelain M. Chimeric antigen receptor therapy. N. Engl J Med. 2018;379:64–73.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Tian Y, Li Y, Shao Y, Zhang Y. Gene modification strategies for next-generation CAR T cells against solid cancers. J Hematol Oncol. 2020;13:54.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Tian Y, Wen C, Zhang Z, Liu Y, Li F, Zhao Q, et al. CXCL9-modified CAR T cells improve immune cell infiltration and antitumor efficacy. Cancer Immunol Immunother. 2022;71:2663–75.

    Article 
    PubMed 

    Google Scholar
     

  • Adachi K, Kano Y, Nagai T, Okuyama N, Sakoda Y, Tamada K. IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor. Nat Biotechnol. 2018;36:346–51.

    Article 
    PubMed 

    Google Scholar
     

  • Li G, Guo J, Zheng Y, Ding W, Han Z, Qin L, et al. CXCR5 guides migration and tumor eradication of anti-EGFR chimeric antigen receptor T cells. Mol Ther Oncolytics. 2021;22:507–17.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Mei Z, Zhang K, Lam AK, Huang J, Qiu F, Qiao B, et al. MUC1 as a target for CAR-T therapy in head and neck squamous cell carinoma. Cancer Med. 2020;9:640–52.

    Article 
    PubMed 

    Google Scholar
     

  • Fultang L, Booth S, Yogev O, Martins B, Tubb V, Panetti S, et al. Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity. Blood. 2020;136:1155–60.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Fu Y, Zou T, Shen X, Nelson PJ, Li J, Wu C, et al. Lipid metabolism in cancer progression and therapeutic strategies. MedComm. 2020;2:27–59.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Emdad L, Bhoopathi P, Talukdar S, Pradhan AK, Sarkar D, Wang XY, et al. Recent insights into apoptosis and toxic autophagy: the roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic. Semin Cancer Biol. 2020;66:140–54.

    Article 
    PubMed 

    Google Scholar
     

  • Casciello F, Kelly GM, Ramarao-Milne P, Kamal N, Stewart TA, Mukhopadhyay P, et al. Combined inhibition of G9a and EZH2 suppresses tumor growth via synergistic induction of IL24-mediated apoptosis. Cancer Res. 2022;82:1208–21.

    Article 
    PubMed 

    Google Scholar
     

  • Pradhan AK, Talukdar S, Bhoopathi P, Shen XN, Emdad L, Das SK, et al. mda-7/IL-24 mediates cancer cell-specific death via regulation of miR-221 and the Beclin-1 axis. Cancer Res. 2017;77:949–59.

    Article 
    PubMed 

    Google Scholar
     

  • Bhoopathi P, Lee N, Pradhan AK, Shen XN, Das SK, Sarkar D, et al. mda-7/IL-24 induces cell death in neuroblastoma through a novel mechanism involving AIF and ATM. Cancer Res. 2016;76:3572–82.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Dash R, Bhoopathi P, Das SK, Sarkar S, Emdad L, Dasgupta S, et al. Novel mechanism of MDA-7/IL-24 cancer-specific apoptosis through SARI induction. Cancer Res. 2014;74:563–74.

    Article 
    PubMed 

    Google Scholar
     

  • Panneerselvam J, Srivastava A, Mehta M, Chen A, Zhao YD, Munshi A, et al. IL-24 inhibits lung cancer growth by suppressing GLI1 and inducing DNA damage. Cancers. 2019;11:1879.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • McKenzie T, Liu Y, Fanale M, Swisher SG, Chada S, Hunt KK. Combination therapy of Ad-mda7 and trastuzumab increases cell death in Her-2/neu-overexpressing breast cancer cells. Surgery. 2004;136:437–42.

    Article 
    PubMed 

    Google Scholar
     

  • Yacoub A, Hamed HA, Allegood J, Mitchell C, Spiegel S, Lesniak MS, et al. PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells. Cancer Res. 2010;70:1120–9.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bhutia SK, Das SK, Azab B, Menezes ME, Dent P, Wang XY, et al. Targeting breast cancer-initiating/stem cells with melanoma differentiation-associated gene-7/interleukin-24. Int J Cancer. 2013;133:2726–36.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cheng JZ, Yu D, Zhang H, Jin CS, Liu Y, Zhao X, et al. Inhibitive effect of IL-24 gene on CD133+ laryngeal cancer cells. Asian Pac J Trop Med. 2014;7:867–72.

    Article 
    PubMed 

    Google Scholar
     

  • Zhang Y, Liu Y, Xu Y. Interleukin-24 regulates T cell activity in patients with colorectal adenocarcinoma. Front Oncol. 2019;9:1401.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wu Z, Liu W, Wang Z, Zeng B, Peng G, Niu H, et al. Mesenchymal stem cells derived from iPSCs expressing interleukin-24 inhibit the growth of melanoma in the tumor-bearing mouse model. Cancer Cell Int. 2020;20:33.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Rao LZ, Wang Y, Zhang L, Wu G, Zhang L, Wang FX, et al. IL-24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing IL-4-induced M2 program in macrophages. Cell Death Differ. 2021;28:1270–83.

    Article 
    PubMed 

    Google Scholar
     

  • Cunningham CC, Chada S, Merritt JA, Tong A, Senzer N, Zhang Y, et al. Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study. Mol Ther. 2005;11:149–59.

    Article 
    PubMed 

    Google Scholar
     

  • Tong AW, Nemunaitis J, Su D, Zhang Y, Cunningham C, Senzer N, et al. Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients. Mol Ther. 2005;11:160–72.

    Article 
    PubMed 

    Google Scholar
     

  • Shi X, Zhang D, Li F, Zhang Z, Wang S, Xuan Y, et al. Targeting glycosylation of PD-1 to enhance CAR-T cell cytotoxicity. J Hematol Oncol. 2019;12:127.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Xuan Y, Sheng Y, Zhang D, Zhang K, Zhang Z, Ping Y, et al. Targeting CD276 by CAR-T cells induces regression of esophagus squamous cell carcinoma in xenograft mouse models. Transl Oncol. 2021;14:101138.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gao Q, Wang S, Li F, Lian J, Cheng S, Yue D, et al. High mobility group protein B1 decreases surface localization of PD-1 to augment T-cell activation. Cancer Immunol Res. 2022;10:844–55.

    Article 
    PubMed 

    Google Scholar
     

  • Zhang K, Zhang L, Mi Y, Tang Y, Ren F, Liu B, et al. A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration. Cancer Sci. 2020;111:4041–50.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cheng S, Li F, Qin H, Ping Y, Zhao Q, Gao Q, et al. Long Noncoding RNA lncNDEPD1 regulates PD-1 expression via miR-3619-5p in CD8(+) T cells. J Immunol. 2022;208:1483–92.

    Article 
    PubMed 

    Google Scholar
     

  • Zhang Y, He L, Sadagopan A, Ma T, Dotti G, Wang Y, et al. Targeting radiation-resistant prostate cancer stem cells by B7-H3 CAR T cells. Mol Cancer Ther. 2021;20:577–88.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Seyfrid M, Maich WT, Shaikh VM, Tatari N, Upreti D, Piyasena D, et al. CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment. J Immunother Cancer. 2022;10:e003289.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Miao Y, Yang H, Levorse J, Yuan S, Polak L, Sribour M, et al. Adaptive immune resistance emerges from tumor-initiating stem cells. Cell. 2019;177:1172–86.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Nusse R, Clevers H. Wnt/beta-Catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169:985–99.

    Article 
    PubMed 

    Google Scholar
     

  • Hu C, Qian L, Miao Y, Huang Q, Miao P, Wang P, et al. Antigen-presenting effects of effector memory Vgamma9Vdelta2 T cells in rheumatoid arthritis. Cell Mol Immunol. 2012;9:245–54.

    Article 
    PubMed 

    Google Scholar
     

  • Li F, Zhang Z, Xuan Y, Zhang D, Liu J, Li A, et al. PD-1 abrogates the prolonged persistence of CD8(+) CAR-T cells with 4-1BB co-stimulation. Signal Transduct Target Ther. 2020;5:164.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Larson RC, Kann MC, Bailey SR, Haradhvala NJ, Llopis PM, Bouffard AA, et al. CAR T cell killing requires the IFNgammaR pathway in solid but not liquid tumours. Nature. 2022;604:563–70.

    Article 
    ADS 
    PubMed 

    Google Scholar
     

  • Hong M, Clubb JD, Chen YY. Engineering CAR-T cells for next-generation cancer therapy. Cancer Cell. 2020;38:473–88.

    Article 
    PubMed 

    Google Scholar
     

  • Fuca G, Reppel L, Landoni E, Savoldo B, Dotti G. Enhancing chimeric antigen receptor t cell efficacy in solid tumors. Clin Cancer Res. 2020;26:2444–51.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhu S, Zhang T, Zheng L, Liu H, Song W, Liu D, et al. Combination strategies to maximize the benefits of cancer immunotherapy. J Hematol Oncol. 2021;14:156.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Fan S, Gao H, Ji W, Zhu F, Sun L, Liu Y, et al. Umbilical cord-derived mesenchymal stromal/stem cells expressing IL-24 induce apoptosis in gliomas. J Cell Physiol. 2020;235:1769–79.

    Article 
    PubMed 

    Google Scholar
     

  • Alizadeh D, Wong RA, Yang X, Wang D, Pecoraro JR, Kuo CF, et al. IL15 enhances CAR-T cell antitumor activity by reducing mTORC1 activity and preserving their stem cell memory phenotype. Cancer Immunol Res. 2019;7:759–72.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     



  • Source link

    Related Articles

    Leave a Reply

    [td_block_social_counter facebook="beingmedicos1" twitter="being_medicos" youtube="beingmedicosgroup" style="style8 td-social-boxed td-social-font-icons" tdc_css="eyJhbGwiOnsibWFyZ2luLWJvdHRvbSI6IjM4IiwiZGlzcGxheSI6IiJ9LCJwb3J0cmFpdCI6eyJtYXJnaW4tYm90dG9tIjoiMzAiLCJkaXNwbGF5IjoiIn0sInBvcnRyYWl0X21heF93aWR0aCI6MTAxOCwicG9ydHJhaXRfbWluX3dpZHRoIjo3Njh9" custom_title="Stay Connected" block_template_id="td_block_template_8" f_header_font_family="712" f_header_font_transform="uppercase" f_header_font_weight="500" f_header_font_size="17" border_color="#dd3333"]
    - Advertisement -spot_img

    Latest Articles